Dura Pharmaceuticals, Inc. v. Broudo
543 U.S. 1134, 160 L. Ed. 2d 1092, 125 S. Ct. 1240, 73 U.S.L.W. 3492, 2005 U.S. LEXIS 1388, 2005 WL 387579
This text of 543 U.S. 1134 (Dura Pharmaceuticals, Inc. v. Broudo) is published on Counsel Stack Legal Research, covering Supreme Court of the United States primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Bluebook
Dura Pharmaceuticals, Inc. v. Broudo, 543 U.S. 1134, 160 L. Ed. 2d 1092, 125 S. Ct. 1240, 73 U.S.L.W. 3492, 2005 U.S. LEXIS 1388, 2005 WL 387579 (2005).
Opinion
C. A. 9th Cir. [Certiorari granted, 542 U. S. 936.] Mo *1135 tion of petitioners for leave to file supplemental brief after argument granted.
Free access — add to your briefcase to read the full text and ask questions with AI
Cite This Page — Counsel Stack
Bluebook (online)
543 U.S. 1134, 160 L. Ed. 2d 1092, 125 S. Ct. 1240, 73 U.S.L.W. 3492, 2005 U.S. LEXIS 1388, 2005 WL 387579, Counsel Stack Legal Research, https://law.counselstack.com/opinion/dura-pharmaceuticals-inc-v-broudo-scotus-2005.